Aldaquin Tablet

About Aldaquin 250 mg Tablet

Aldaquin 250 mg Tablet is an anti-malarial medicine containing chloroquine phosphate. It is used to treat and prevent malaria and for some other conditions. The doctor decides the dose and course.

There are 24 brands of Chloroquine Phosphate listed in Bangladesh. The lowest listed price is Jasochlor 250 mg Tablet at ৳ 1.21 per unit.

What is Aldaquin 250 mg Tablet?

Aldaquin 250 mg Tablet is a medicine from Albert David that contains chloroquine phosphate, which belongs to the anti-malarial group. It works against the malaria parasite in the blood and is used for treating and preventing malaria. It is also used for amoebic hepatitis and abscess, and for rheumatoid arthritis and lupus. The doctor decides the dose and course. It is not for self-medication. Always follow the doctor's instructions and tell them about other medicines you take.

Uses of Aldaquin

Aldaquin 250 mg Tablet is used to treat malaria and to prevent and suppress malaria. It is also used to treat amoebic hepatitis and amoebic abscess, and to treat discoid and systemic lupus erythematosus and rheumatoid arthritis. Only a doctor can decide if it is suitable for you and how long you should take it.

How to use Aldaquin

Take Aldaquin 250 mg Tablet only as your doctor prescribes. Swallow the tablet with water. The doctor will decide the dose and how long you should take it. Do not change the dose or stop the course on your own. If you forget a dose, ask your doctor or pharmacist what to do. Keep the medicine out of reach of children.

Side effects of Aldaquin

Aldaquin 250 mg Tablet is usually well tolerated at standard doses. Some people may get headache or stomach upset, which are not serious. With long-term high doses, side effects can be more serious: skin rash, occasional loss of skin colour or hair, difficulty in focusing, and blurred vision. Rarely, blood problems such as low platelets or anaemia have been reported. The most serious risk of long-term use is eye damage. Tell your doctor if you notice any side effects.

Safety and precautions

Avoid using Aldaquin 250 mg Tablet in pregnancy if possible, unless your doctor decides the benefit outweighs the risk. Ask your doctor about breastfeeding. Caution is needed if you have porphyria, liver problems, or cirrhosis, especially if you drink alcohol. If you take it for a long time, your doctor may arrange eye checks. Tell your doctor about all other medicines you take and about any allergies. Ask your doctor before starting this medicine if you have any health conditions.

Frequently asked questions

Is Aldaquin 250 mg Tablet safe in pregnancy or breastfeeding?

The use of chloroquine during pregnancy should be avoided if possible, unless the doctor judges that the benefit outweighs the risk for a threatening infection. Ask your doctor about breastfeeding. Do not start or stop this medicine without medical advice.

What is Aldaquin 250 mg Tablet used for and what kind of medicine is it?

Aldaquin 250 mg Tablet is an anti-malarial medicine containing chloroquine phosphate. It is used to treat malaria and to prevent and suppress malaria. It is also used for amoebic hepatitis and abscess, rheumatoid arthritis, and discoid and systemic lupus erythematosus.

What does the generic name chloroquine phosphate mean?

The generic name chloroquine phosphate refers to the active ingredient in this medicine. Chloroquine is a substance that acts against the malaria parasite in the blood. The phosphate part is the salt form used in the tablet. Your doctor or pharmacist can explain more.

What should I tell my doctor before taking Aldaquin 250 mg Tablet?

Tell your doctor if you are pregnant or breastfeeding, or if you have porphyria, liver problems, or cirrhosis. Also mention all other medicines you take. Your doctor will decide if this medicine is suitable for you and will arrange any necessary checks.

Indications

Chloroquine Phosphate is indicated in the following cases:
  • Treatment of malaria
  • Prophylaxis and suppression of malaria
  • Treatment of amoebic hepatitis and abscess
  • Treatment of discoid and systemic and systemic lupus erythematosus
  • Treatment of rheumatoid arthritis

Pharmacology

Chloroquine is used for malarial prophylaxis (as a suppressive) and in managing acute attacks of malaria. It is highly active against erythrocytic forms of P. vivax, P. malariae and P. falciparum. It influences Hb digestion by increasing intravesicular pH in malaria parasite cells and interferes with the nucleoprotein synthesis of the patient. It is also effective in extra intestinal amoebiasis. In RA chloroquine and more effectively hydroxychloroquine have a disease-modifying effect.

Dosage & Administration

Treatment of Malaria-

Partially immune adults:

A single dose of 4 tablets. In severe attacks, the dosage schedule for non-immune adults should be adopted.

Partially immune children:

  • Under 1 year: 1-2 single dose (in 5 ml spoonful)
  • 1-3 years: 3-4 single dose (in 5 ml spoonful)
  • 3-6 years: 4-6 single dose (in 5 ml spoonful)
  • 6-9 years: 6-9 single dose (in 5 ml spoonful)
In severe attacks, the dosage schedule for non-immune children should be adopted.

Non-immune adults:

  • P. falciparum infections: 4 tablets initially, 2 tablets after 6 to 8 hours and then 2 tablets per day for 2 days
  • P. vivax group infections: A single dose of four tablets followed by a course of treatment with primaquine phosphate (15 mg base daily for fourteen days)

Non-immune Children:

Under 1 year:
  • 1-2 initial dose (in 5 ml spoonful)
  • 1 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
1-3 years:
  • 3-4 initial dose (in 5 ml spoonful)
  • 1-2 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
3-6 years:
  • 4-6 initial dose (in 5 ml spoonful)
  • 2-3 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
6-9 years :
  • 6-9 initial dose (in 5 ml spoonful)
  • 3-5 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)

Prophylaxis and suppression of Malaria-

Adults: 2 tablets taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.

Children (Syrup): The following doses should be taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.
  • Under 1 year: 1 single dose (in 5 ml spoonful)
  • 1-3 years: 2 single dose (in 5 ml spoonful)
  • 3-6 years: 2-3 single dose (in 5 ml spoonful)
  • 6-9 years: 3-5 single dose (in 5 ml spoonful)
Children (Tablets): For practical purpose, children over 12 years may be treated as adults and for those below this age, the following proportions may be applied.
  • Under 1 year: ⅛ adult dose (¼ tablet)
  • 1-4 years: ¼ adult dose (½ tablet)
  • 4-8 years: ½ adult dose (1 tablet)
  • 8-12 years: ¾ adult dose (1.5 tablet)

Interaction

Concomitant therapy with phenylbutazone predisposes to dermatitis, antagonises effect of neostigmine and pyridostigmine, reduces bioavailability of ampicillin. Cimetidine inhibits metabolism of chloroquine raising plasma levels.

Contraindications

There is no absolute contraindication to the use of chloroquine.

Side Effects

Choroquine is well tolerated at the standard dosage regimens, side effects such as headache and gastrointestinal disturbances which may occur are not of a serious nature. Where prolonged high dose is required side effects can be of greater severity and patients may develop skin eruptions, occasional depigmentation or loss of hair, difficulty in accommodation, blurring of vision. Corneal opacities disappear completely when the drug is stopped. Rarely thrombocytopenia, agranulocytosis and aplastic anemia have been reported.

The most serious toxic hazard of prolonged therapy with doses is the occasional development of irreversible retinal damage. For this reason considerable caution is needed in the use of choroquine for long-term high dosage therapy and such use should only be considered when no other drug is available. Defects in visual accommodation may occur on first taking choloquine and patients should be warned regarding driving or operating machinery.

Pregnancy & Lactation

As with all other drugs, the use of choroquine during pregnancy should be avoided if possible, unless in the case of threatening infections, in the judgment of the physician, when the potential benefit outweighs the risk.

Precautions & Warnings

Caution is necessary when giving choroquine to patients with porphyria who also have hepatic dysfunction or cirrhosis as the drug may precipitate severe constitutional symptoms and an increase in the amount of porphyrins excreted in the urine. This reaction is especially apparent in alcoholics. Patients receiving choloquine continuously at higher dose levels for a period longer than 12 months or at weekly intervals for a period of more than 3 years as prophylactic against malaria (or the consumption exceeds 1.6 g/Kg) should undergo ophthalmic examination at three months interval.

Storage Conditions

Store at room temperature in a dry place, away from light.

Alternative brands of Chloroquine Phosphate

Other brands with the same generic name, cheapest first.

See all 24 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.